Expired contract

Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025

Details

Value
GBP 105,600
Duration
1 year
Topic
Pharmaceutical products
Published
24 January 2025

Tender description

Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo. Additional information: Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.

Timeline

  1. Completed: Award date1 January 2025
  2. Completed: Award published24 January 2025
    Current notice
  3. Completed: Contract expiry date31 December 2025

About the buyer

United Lincolnshire Teaching Hospitals NHS Trust is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

6 similar open tenders

See more open tenders related to Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025.

Explore all open tenders

Related buyers

Buyers similar to United Lincolnshire Teaching Hospitals NHS Trust.

View all buyers

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.